Evidence map›Paper›PMID 30386808›Full record

ArticleOpen forum infectious diseases2018

The Facility-Level HIV Treatment Cascade: Using a Population Health Tool in Health Care Facilities to End the Epidemic in New York State.

Daniel J Ikeda, Leah Hollander, Susan Weigl, Steven V Sawicki, Daniel R Belanger, Nova Y West, Nanette Brey Magnani, Christopher G Wells, Peter Gordon, Johanne Morne and 1 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daniel J IkedaNew York State Department of Health AIDS Institute, New York, New York.
Leah HollanderNew York State Department of Health AIDS Institute, New York, New York.
Susan WeiglNew York State Department of Health AIDS Institute, New York, New York.
Steven V SawickiNew York State Department of Health AIDS Institute, New York, New York.
Daniel R BelangerNew York State Department of Health AIDS Institute, New York, New York.
Nova Y WestNew York State Department of Health AIDS Institute, New York, New York.
Nanette Brey MagnaniNew York State Department of Health AIDS Institute, New York, New York.
Christopher G WellsNew York State Department of Health AIDS Institute, New York, New York.
Peter GordonDivision of Infectious Diseases, Department of Medicine, Columbia University, New York, New York.
Johanne MorneNew York State Department of Health AIDS Institute, New York, New York.
Bruce D AginsNew York State Department of Health AIDS Institute, New York, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe HIV treatment cascade is a tool for characterizing population-level gaps in HIV care, yet most adaptations of the cascade rely on surveillance data that are ill-suited to drive quality improvement (QI) activities at the facility level. We describe the adaptation of the cascade in health care organizations and report its use by HIV medical providers in New York State (NYS).

methodsAs part of data submissions to the NYS Department of Health, sites that provide HIV medical care in NYS developed cascades using facility-generated data. Required elements included data addressing identification of people living with HIV (PLWH) receiving any service at the facility, linkage to HIV medical care, prescription of antiretroviral therapy (ART), and viral suppression (VS). Sites also submitted a methodology report summarizing how cascade data were collected and an improvement plan identifying care gaps.

resultsTwo hundred twenty-two sites submitted cascades documenting the quality of care delivered to HIV patients presenting for HIV- or non-HIV-related services during 2016. Of 101 341 PLWH presenting for any medical care, 75 106 were reported as active in HIV programs, whereas 21 509 had no known care status. Sites reported mean ART prescription and VS rates of 94% and 80%, respectively, and 60 distinct QI interventions.

conclusionsSubmission of facility-level cascades provides data on care utilization among PLWH that cannot be assessed through traditional HIV surveillance efforts. Moreover, the facility-level cascade represents an effective tool for identifying care gaps, focusing data-driven improvement efforts, and engaging frontline health care providers to achieve epidemic control.

Indexed as

care engagementHIV treatment cascadequality of care

Identifiers

PMID30386808
PMCPMC6202506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.